The store will not work correctly when cookies are disabled.
N-(3-Carbamoylphenyl)quinoline-3-carboxamide
ID: ALA4752914
PubChem CID: 139568440
Max Phase: Preclinical
Molecular Formula: C17H13N3O2
Molecular Weight: 291.31
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: NC(=O)c1cccc(NC(=O)c2cnc3ccccc3c2)c1
Standard InChI: InChI=1S/C17H13N3O2/c18-16(21)12-5-3-6-14(9-12)20-17(22)13-8-11-4-1-2-7-15(11)19-10-13/h1-10H,(H2,18,21)(H,20,22)
Standard InChI Key: GWCGSBPPIXXSMV-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
5.9880 -10.7153 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8130 -10.7105 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2297 -11.4226 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.2213 -9.9936 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.0464 -9.9887 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4609 -10.7026 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2853 -10.6982 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6944 -9.9806 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2732 -9.2662 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4503 -9.2743 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6791 -8.5457 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5040 -8.5379 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.2598 -7.8350 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.5742 -10.0027 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7620 -11.4391 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.5848 -11.4311 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3408 -10.7247 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7518 -10.0083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3370 -9.2963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5114 -9.2994 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1023 -10.0205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5193 -10.7296 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
2 4 1 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
11 12 1 0
11 13 2 0
9 11 1 0
1 14 2 0
14 18 1 0
17 15 1 0
15 16 2 0
16 1 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 17 2 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 291.31 | Molecular Weight (Monoisotopic): 291.1008 | AlogP: 2.59 | #Rotatable Bonds: 3 |
Polar Surface Area: 85.08 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 2.94 | CX LogP: 2.07 | CX LogD: 2.07 |
Aromatic Rings: 3 | Heavy Atoms: 22 | QED Weighted: 0.78 | Np Likeness Score: -1.71 |
References
1. Nijampatnam B,Ahirwar P,Pukkanasut P,Womack H,Casals L,Zhang H,Cai X,Michalek SM,Wu H,Velu SE. (2021) Discovery of Potent Inhibitors of Streptococcus mutans Biofilm with Antivirulence Activity., 12 (1): [PMID:33488963] [10.1021/acsmedchemlett.0c00373] |